›› 2014, Vol. 29 ›› Issue (1): 93-94.DOI: 10.3969/j.issn.1673-8640.2014.01.023
Previous Articles Next Articles
Received:2013-02-01
Online:2014-01-20
Published:2014-01-20
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2014.01.023
| [1] 李远眺, 覃 兰.胱抑素-C在肾脏疾病中的应用价值[J].右江医学, 2007, 35(1): 37-38. [2] 马清光, 李慧敏, 沈 丽, 等.血清半胱氨酸蛋白酶抑制剂C、肌酐评估慢性肾脏病患者肾小球滤过功能价值的Meta分析[J].检验医学, 2012, 27(5):352-357. [3] 王 斌, 屈 靖, 范进东, 等.中老年表面健康人群血清半胱氨酸蛋白酶抑制剂C的异常表达及临床意义[J].检验医学, 2013, 28(5):419. [4] 韩秀晶, 万舒婷, 吴 颉, 等.正常妊娠期胱抑素血清代谢变化的研究[J].广州医药, 2010, 41(5):46-48. [5] 鄢 斌. 血清胱抑素C在早、中、晚各期妊娠中的水平调查[J].中国优生与遗传杂志, 2009, 29(8):47. [6] 唐章平.早期妊娠高血压综合征患者Cys C、NAG的变化[J].检验医学, 2013, 28(5):356. [7] 罗红权, 陈新敏, 薛 峰.妊娠高血压综合征患者血清胱抑素C检测的临床应用[J].实用医学杂志, 2010, 26(10):1825-1826. [8] 郁 森, 张 莉, 秦 岳.血清半胱氨酸酶蛋白酶抑制剂C在重度子痫前期诊断中的临床意义[J].检验医学, 2013, 28(6):471-474. [9] Saxena AR, Ananth Karumanchi S, Fan SL, et al.Correlation of cystatin-C with glomerular filtration rate by inulin clearance in pregnancy[J]. Hypertens Pregnancy, 2012, 31(1):22-30. [10] Kos J, Krasovec M, Cimerman N, et al.Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis[J].Clin Cancer Res, 2000, 6(2): 505-511. [11] Fricker M, Wiesli P, Brndle M, et al.Impact of thyroid dysfunction on serum cystatin C[J].Kidney Int, 2003, 63(5): 1944-1947. [12] Bkenkamp A, van Wijk JA, Lentze MJ, et al. Effect of corticosteroid therapy on serum cystatin C and beta 2-microglobulin concentrations[J].Clin Chem, 2002, 48(7): 1123-1126. [13] Abrahamson M, Olafsson I, Palsdottir A, et al. Structure and expression of the human cystatin C gene[J].Biochem J, 1990, 268(2): 287-294. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
